Summary Nobel Biocare Services AG (Nobel Biocare), a subsidiary of Danaher Corporation, is a provider of implant-based dental restorations.The company offers various solutions, including dental implant systems; high-precision individualized prosthetics; CAD/CAM systems; diagnostics and treatment planning; guided surgery solutions; and biomaterials.
It also provides training and education, and practice support and patient information materials to its customers.Nobel Biocare has production sites in the US, Sweden, Japan and Israel.
The company distributes products directly and also through a network of distributors across the Americas, Europe, the Middle East and Africa, Asia Pacific. Nobel Biocare is headquartered in Zurich, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Nobel Biocare Services AG - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
The global implantable medical devices market exhibited moderate growth during 2015-2020. Medical implants are devices that are used to replace or act as a fraction for a particular body part or for the whole biological structure. Every year thousands of people enhance the quality of their lives by going through surgical...
The disposable medical device sensors market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for...
The implementation of track and trace solutions and technologies is an important strategy adopted by many manufacturing companies and regulatory bodies in recent years. The global track and trace solutions market is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period. Growth...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Antimicrobial Medical Device Market Report
The global antimicrobial medical device coatings market by revenue is expected to grow at a CAGR of over 7% during the period 2021–2026.
The antimicrobial medical device coatings market constitutes...
136 pages •
By Global Industry Analysts
• Apr 2021
- Global Connected Medical Devices Market to Reach $46.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Connected Medical Devices estimated at US$26 Billion in the year 2020, is projected to reach a revised size of US$46.2 Billion by 2027, growing at a CAGR of 8.6% over the analysis period...
The global intraoperative imaging market size is projected to reach USD 2.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 5.2%. Factors such as the technological advancements in the market are propelling the growth of the intraoperative imaging market. Additionally, rising cases of surgeries, investments from both private and...
China Cardiovascular Devices Market Outlook to 2025 - Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
“China Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the China Cardiovascular...
Australia Cardiovascular Devices Market Outlook to 2025 - Aortic and Vascular Graft Devices, Atherectomy Devices, Cardiac Assist Devices and Others
“Australia Cardiovascular Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Australia Cardiovascular...
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
The medical affairs outsourcing market was valued at US$ 1,415.00 million in 2019 and is projected to reach US$ 3,287.12 million by 2027; it is expected to grow at a CAGR of 11.2% from 2020 to 2027. Growing number of clinical trials worldwide and rising adoption of outsourcing activities coupled with increasing R&D expenditures are...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.